This systematic review highlights consistent associations between increased pro-inflammatory cytokines (i.e., IL-6, IL-1β, TNF-α), reduced levels of hippocampal BDNF, and cognitive impairment in preclinical models of breast cancer and chemotherapy. This evidence concerns the gene IL6 and breast carcinoma.